United States Market Report for Orthopedic Hyaluronic Acid Viscosupplementation 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "US Market Report for Orthopedic Hyaluronic Acid Viscosupplementation 2017 - MedCore" report to their offering.

Hyaluronic acid products involve one, two, three or five-dose cycles, with the actual number of doses taken often being less than a full treatment. The growth of single-injection products over three- and five-injection products has been the most significant trend in the market. The single-injection has, to some extent, cannibalized other injection types; the convenience of the single-injection procedure has aided market penetration.

The introduction of a two injection product in 2016 will further squeeze market share from the three- and five-injection products. Furthermore, viscosupplementation is beginning to be an expected treatment before joint replacement; this will drive unit sales growth.

As of 2016, both the single-injection and triple-injection markets were approximately the same in terms of market value, with the triple-injection being a little larger. While the three-injection market continues its positive growth, the collective hyaluronic acid viscosupplementation market is shifting to single-injection. The single-injection market is expected to become the largest segment of the HA market in the next couple of years because due to ease-of-use.

Key Topics Covered:

1. Research Methodology

2. Disease Overview

2.1 Basic Anatomy

2.1.1 Osteology And Musculoskeletal System

2.2 Disease Pathology And Disorders

2.2.1 General Diagnostic

2.2.2 Osteoporosis

2.2.3 Osteoarthritis

2.2.4 Indication For Bone Graft Procedure

2.2.5 Indication For Cartilage Repair

2.2.6 Degenerative Disc Disease

2.3 Patient Demographics

2.3.1 General Statistics

3. Product Assessment

3.1 Product Portfolios

3.1.1 Hyaluronic Acid Viscosupplementation

3.2 Regulatory Issues And Recalls

3.2.1 Hyaluronic Acid Viscosupplementation

3.3 Clinical Trials

3.3.1 Hyaluronic Acid Viscosupplementation

4. Orthopedic Hyaluronic Acid Viscosupplementation Market

4.1 Introduction

4.1.1 Benefits Of Viscosupplementation

4.1.2 Synovial Fluid

4.1.3 Product Types

4.1.4 Reimbursement

4.2 Market Overview

4.3 Market Analysis And Forecast

4.3.1 Total Hyaluronic Acid Viscosupplementation Market

4.4 Drivers And Limiters

4.5 Competitive Market Share Analysis

Companies Mentioned

  • Medtronic
  • Genzyme
  • DePuy Synthes
  • Anika Therapeutics
  • Ferring Pharmaceuticals
  • Stryker
  • NuVasive
  • Bioventus
  • Zimmer Biomet
  • Integra LifeSciences
  • RTI Surg

For more information about this report visit http://www.researchandmarkets.com/research/q76qlv/us_market_report

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs, Orthopedic Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs, Orthopedic Devices